Drugs
USC Scholar Proposes Conditional FDA Drug Approvals Based on Phase 2 Trials
FDA should consider allowing certain investigational drugs onto the market following successful randomized Phase 2 trials, subject to completion of confirmatory studies, according to a proposal by University of Southern California health economist Neeraj Sood. Writing in an 11/19 Washington Post opinion article, Sood, a senior scholar at USC&